Article PDF
Avoid common mistakes on your manuscript.
References
Wilkinson GR, Shand DG. A physiological approach to the hepatic drug clearance. Clin Pharmacol Ther 1975; 18: 377–90.
Shanks CA. Pharmacokinetics of the nondepolarizing neuromuscular relaxants applied to the calculation of bolus and infusion dosage regimens. Anesthesiology 1986; 64: 72–86.
Burch PG, Stanski DR. The role of metabolism and protein binding in thiopental anesthesia. Anesthesiology 1983; 58: 146–52.
Sohn YJ, Bencini AF, Scaf AHJ, Kersten UW, Agoston S. Comparative pharmacokinetics and dynamics of vecuronium and pancuronium in anesthetized patients. Anesth Analg 1986; 65: 233–9.
Cook DR, Wingard LB, Taylor FH. Pharmacokinetics of succinylcholine in infants, children and adults. Clin Pharmacol Ther 1976; 20: 493–8.
Merrett RA, Thompson CW, Webb FW. In vitro degradation of atracurium in human plasma. Br J Anaesth 1983; 55: 61–6.
Stiller RL, Cook DR, Chakravorti S. In vitro degradation of atracurium in human plasma. Br J Anaesth 1985; 1085–8.
Ward S, Boheimer N, Weatherley BC, Simmonds RJ, Dopson TA. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure. Br J Anaesth 1987; 59: 697–706.
Tsui D, Graham GG, Torda TA. The pharmacokinetics of atracurium isomers in vitro and in humans. Anesthesiology 1987; 67: 722–8.
Fisher DM, Canfell PC, Fahey MR et al. Elimination of atracurium in humans: contribution of Hofmann elimination and ester hydrolysis versus organ-based elimination. Anesthesiology 1986; 65: 6–12.
Miller RD, Agoston S, Booij LHD, Kersten UW, Crul JF, Ham J. The comparative potency and pharmacokinetics of pancuronium and its metabolites in anesthetized man. J Pharmacol Exp Ther 1978; 207: 539–43.
Brennan HJ. Dual action of suxamethonium chloride. Br J Anaesth 1956; 28: 159–68.
Chappie DJ, Miller AA, Ward JB, Wheatley PL. Cardiovascular and neurological effects of laudanosine. Studies in mice and rats, and in conscious and anaesthetized dogs. Br J Anaesth 1987; 59: 218–25.
Bowman WC, Rodger IW, Houston J, Marshall RJ, Mc-Indewar I. Structure:action relationships among some desacetoxy analogues of pancuronium and vecuronium in the anesthetized cat. Anesthesiology 1988; 69: 57–62.
Nigrovic V, Pandya JB, Auen M, Wajskol A. Inactivation of atracurium in human and rat plasma. Anesth Analg 1985; 64: 1047–52.
Nigrovic V, Klaunig JE, Smith SL, Schultz NE, Wajskol A. Comparative toxicity of atracurium and metocurine in isolated rat hepatocytes. Anesth Analg 1986; 65: 1107–11.
Nigrovic V, Smith S. Involvement of nucleophiles in the inactivation of atracurium. Br J Anaesth 1987; 59: 617–21.
Nigrovic V, Pandya JB, Klaunig JE, Fry K. Reactivity and toxicity of atracurium and its metabolitesin vitro. Can J Anaesth 1989; 36: 262–8 (current journal).
Parker CJR, Jones JE, Hunter JM. Disposition of infusions of atacurium and its metabolite, laudanosine, in patients in renal and respiratory failure in an ITU. Br J Anaesth 1988; 61:531–40.
Weber S, Brandom BW, Powers DM et al. Mivacurium chloride (BW 1090U)-induced neuromuscular blockade during nitrous oxide-narcotic anesthesia in adult surgical patients. Anesth Analg 1988; 67: 495–9.
Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW 1090U). Anesthesiology 1988; 68: 723–32.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donati, F. Atracurium, pharmacokinetics and metabolites. Can J Anaesth 36, 257–261 (1989). https://doi.org/10.1007/BF03010761
Issue Date:
DOI: https://doi.org/10.1007/BF03010761